GelStat Financial Statements From 2010 to 2024
| GSAC Stock | USD 0.0004 0.0001 33.33% |
Check GelStat Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GelStat Corp's main balance sheet or income statement drivers, such as , as well as many indicators such as . GelStat financial statements analysis is a perfect complement when working with GelStat Corp Valuation or Volatility modules.
GelStat |
GelStat Corp Company Operating Margin Analysis
GelStat Corp's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current GelStat Corp Operating Margin | (127.79) % |
Most of GelStat Corp's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GelStat Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, GelStat Corp has an Operating Margin of -127.7943%. This is 264.29% higher than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The operating margin for all United States stocks is notably higher than that of the company.
GelStat Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GelStat Corp's current stock value. Our valuation model uses many indicators to compare GelStat Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GelStat Corp competition to find correlations between indicators driving GelStat Corp's intrinsic value. More Info.GelStat Corp is one of the top stocks in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value GelStat Corp by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for GelStat Corp's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About GelStat Corp Financial Statements
GelStat Corp stakeholders use historical fundamental indicators, such as GelStat Corp's revenue or net income, to determine how well the company is positioned to perform in the future. Although GelStat Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in GelStat Corp's assets and liabilities are reflected in the revenues and expenses on GelStat Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in GelStat Corp. Please read more on our technical analysis and fundamental analysis pages.
GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. Gelstat Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in GelStat Pink Sheet
GelStat Corp financial ratios help investors to determine whether GelStat Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GelStat with respect to the benefits of owning GelStat Corp security.